SGOL2 Is a Novel Prognostic Marker and Fosters Disease Progression via a MAD2-Mediated Pathway in Hepatocellular Carcinoma

Scientists examined the potential role of SGOL2 in cancers, especially in HCC.Immunohistochemistry, immunofluorescence, western blot, Co-Immunoprecipitation technique, and bioinformatic analysis were utilized to assess the role of SGOL2 in HCC development process.